Future of the Diphtheria Market: Insights, Developments, and Strategic Overview

 Created for forward-thinking professionals, this report equips teams with the insights needed to compete effectively in the diphtheria space.

 

 How Much Is The Diphtheria Market Worth?
 The diphtheria market size has grown strongly in recent years. It will grow from $8.91 billion in 2024 to $9.39 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to vaccine development, immunization campaigns, increased awareness, healthcare infrastructure.
 
 The diphtheria market size is expected to see strong growth in the next few years. It will grow to $12.1 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to emerging outbreaks, booster vaccination programs, global travel and migration, public health preparedness. Major trends in the forecast period include combination vaccines, telemedicine for vaccination, vaccine equity initiatives, public-private partnerships.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp
 
 What Are The Current Leading Growth Drivers For Diphtheria Market?
 The rising prevalence of bacterial infections is expected to propel the growth of the diphtheria market going forward. A bacterial infection is a sickness or condition attributed to bacterial growth or the toxins produced by bacteria that invade the body. Diphtheria is a serious infection caused by bacteria strains that suppress the immune system and promote the proliferation of Corynebacterium diphtheria. For instance, in September 2024, according to GOV.UK, a UK-based government website, during the fiscal year 2022 to 2023, NHS acute trusts in England reported a total of 38,757 cases of E. coli bacteremia, with 7,881 cases (20.3%) identified as hospital-onset infections. Therefore, the rising prevalence of bacterial infections will drive the diphtheria market. 
 
 Which Segment Accounted For The Largest Diphtheria Market Share?
 The diphtheriamarket covered in this report is segmented — 
 
 1) By Type: Diphtheria; Skin Diphtheria; Other Types
 2) By Diagnosis: Physical Examination; Throat Culture; Other Diagnosis
 3) By Treatment: Antibiotics; Antitoxin; Other Treatments
 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
 5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
 
 Subsegments:
 1) By Diphtheria: Respiratory Diphtheria; Non-respiratory Diphtheria
 2) By Skin Diphtheria: Cutaneous Diphtheria
 3) By Other Types: Diphtheritic Myocarditis; Diphtheritic Neuritis
 
 Diphtheria Market Future Trends
 Major companies operating in the diphtheria market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in October 2022, GlaxoSmithKline PLC, a UK-based pharmaceutical and biotechnology company, announced that the US Food and Drug Administration (FDA) approved BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap) for immunization throughout the third month of the pregnancy to help prevent pertussis (whooping cough) in infants younger than two months of age. The Tdap immunization administered during pregnancy gives the highest protection against whooping cough in the early months of life for newborns. Protective antibodies are transferred from mother to kid when pregnant women are immunized.
 
 Which Are The Top Companies To Hold The Market Share In Diphtheria Market?
 Major companies operating in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.
 
 View the full diphtheria market report here:
 https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report
 
 Which Region Is Projected To Account For The Largest Share Of The Diphtheria Market?
 Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company